130 related articles for article (PubMed ID: 2557231)
1. VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A.
Rouyer-Fessard C; Augeron C; Grasset E; Maoret JJ; Laboisse CL; Laburthe M
Experientia; 1989 Dec; 45(11-12):1102-5. PubMed ID: 2557231
[TBL] [Abstract][Full Text] [Related]
2. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
[TBL] [Abstract][Full Text] [Related]
3. Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E.
Laburthe M; Augeron C; Rouyer-Fessard C; Roumagnac I; Maoret JJ; Grasset E; Laboisse C
Am J Physiol; 1989 Mar; 256(3 Pt 1):G443-50. PubMed ID: 2538074
[TBL] [Abstract][Full Text] [Related]
4. Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.
Laburthe M; Rousset M; Rouyer-Fessard C; Couvineau A; Chantret I; Chevalier G; Zweibaum A
J Biol Chem; 1987 Jul; 262(21):10180-4. PubMed ID: 3038870
[TBL] [Abstract][Full Text] [Related]
5. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29.
Turner JT; Jones SB; Bylund DB
Peptides; 1986; 7(5):849-54. PubMed ID: 3025826
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
Rodríguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
Charlton BG; Neal DE; Simmons NL
J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
10. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide control of renal adenylate cyclase: in vitro studies of canine renal membranes and cultured canine renal epithelial (MDCK) cells.
Griffiths NM; Rugg EL; Simmons NL
Q J Exp Physiol; 1989 May; 74(3):339-53. PubMed ID: 2546173
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.
O'Dorisio MS; Fleshman DJ; Qualman SJ; O'Dorisio TM
Regul Pept; 1992 Feb; 37(3):213-26. PubMed ID: 1313595
[TBL] [Abstract][Full Text] [Related]
13. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol modulation of membrane fluidity and VIP receptor/effector system in rat prostatic epithelial cells.
Carmena MJ; Hueso C; Guijarro LG; Prieto JC
Regul Pept; 1991 May; 33(3):287-97. PubMed ID: 1652781
[TBL] [Abstract][Full Text] [Related]
15. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
[TBL] [Abstract][Full Text] [Related]
16. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
18. VIP and related peptides induce rapid homologous desensitization in the human lymphoma SUP T1 cell line.
Robberecht P; De Neef P; Waelbroeck M; Tastenoy M; Christophe J
Peptides; 1989; 10(2):441-6. PubMed ID: 2474155
[TBL] [Abstract][Full Text] [Related]
19. High affinity vasoactive intestinal peptide receptors on fetal human nonpigmented ciliary epithelial cells.
Crook RB; Lui GM; Alvarado JA; Fauss DJ; Polansky JR
Curr Eye Res; 1994 Apr; 13(4):271-9. PubMed ID: 8033589
[TBL] [Abstract][Full Text] [Related]
20. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
